|
|
Article: Evaluation in nonhuman primates of vaccines against Ebola virus. (Perspectives).
- Article from:
- Emerging Infectious Diseases
- Article date:
- May 1, 2002
- Author:
CopyrightCOPYRIGHT 2002 U.S. National Center for Infectious Diseases. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ebola virus (EBOV) causes acute hemorrhagic fever that is fatal in up to 90% of cases in both humans and nonhuman primates. No vaccines or treatments are available for human use. We evaluated the effects in nonhuman primates of vaccine strategies that had protected mice or guinea pigs from lethal EBOV infection. The following immunogens were used: RNA replicon particles derived from an attenuated strain of Venezuelan equine encephalitis virus (VEEV) expressing EBOV glycoprotein and nucleoprotein; recombinant Vaccinia virus expressing EBOV glycoprotein; liposomes containing lipid A and inactivated EBOV; and a concentrated, inactivated whole-virion preparation. None of these ...
Related newspaper, magazine, and journal articles:
|
|
Article: The C. Porcellus: (a.k.a.) pocket pet.(caring for guinea ...
Hopscotch;
August 1, 2002 ;
700+ words
... ... otherwise known as a "pocket pet." So what are guinea pigs? Guinea pigs, like beavers, rats, and squirrels are rodents ... explorers. Dutch traders then brought them to Europe. Guinea pigs grow between 10 to 14 inches in length and are ...
|
|